LAURUS LABS LIMITED Intrinsic Value
LAURUSLABS · Healthcare · Current price ₹1,831.5
Is LAURUS LABS LIMITED undervalued?
DocStoX estimates the fair value of LAURUS LABS LIMITED at ₹499 per share, versus the current market price of ₹1,832. That puts the stock about -72.8% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹125), Relative P/E (₹644), Graham floor (₹191), Analyst target (₹1,493). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹125 (bear) to ₹499 (base) to ₹1,493 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹1,832 versus an intrinsic value of ₹499, LAURUS LABS LIMITED currently offers -72.8% of negative margin (i.e. a premium).
More on LAURUS LABS LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.